Ernexa Therapeutics announces 1-for-25 reverse stock split

Ernexa Therapeutics announced a reverse stock split of its issued and outstanding shares of common stock, par value $0.005 per share, at a ratio of 1-for-25, effective May 4 at 12:01 a.m. Eastern Time. The company’s common stock is expected to begin trading on a split-adjusted basis when the market opens on May 4 under the existing trading symbol (ERNA). The company is effecting the reverse split to regain compliance with the $1.00 minimum bid price required for continued listing on Nasdaq under Nasdaq Listing Rule 5550.